POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE

Currently, nonsteroidal anti-inflammatory drugs (NSAIDs) are a major component of pharmacotherapy of chronic rheumatic pain and are the most commonly prescribed drugs. The cyclooxygenase (COX) – a key enzyme in the synthesis of prostaglandins (PG) mediating the inflammation development – is the targ...

Full description

Bibliographic Details
Main Authors: Y. A. Olyunin, N. Y. Nikishina
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-11-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2157
_version_ 1827962018943991808
author Y. A. Olyunin
N. Y. Nikishina
author_facet Y. A. Olyunin
N. Y. Nikishina
author_sort Y. A. Olyunin
collection DOAJ
description Currently, nonsteroidal anti-inflammatory drugs (NSAIDs) are a major component of pharmacotherapy of chronic rheumatic pain and are the most commonly prescribed drugs. The cyclooxygenase (COX) – a key enzyme in the synthesis of prostaglandins (PG) mediating the inflammation development – is the target for NSAIDs. The use of NSAIDs is associated with risk of mucosal damage of the gastrointestinal tract (GIT). Its protection is carried out with the participation of PG, the synthesis of which is controlled primarily by COX1, to a lesser extent – by COX2, inducing an inflammatory process. Therefore, one of the most effective measures to prevent disorders of the gastrointestinal tract, was the development of drugs that selectively inhibit the activity of COX2. Such drugs include, in particular, nimesulide (NM Nimesin, Shreya Life Senses). In addition to synthesis of PG-mediated COX2, NM inhibits a number of other mechanisms involved in the development of the inflammatory process. The ability of the NM to act simultaneously on many parts of the inflammatory process allows successfully using it in various inflammation-associated disease. NM was covered in over 200 clinical trials that included more than 90 thousand patients with acute and chronic diseases accompanied by pain syndrome. These authors demonstrated that NM can significantly reduce pain, being not inferior by effectiveness than any of the NSAIDs both: selective and non-selective. At the same the sparing effect of NM on COX1 allows maintaining sufficient concentration of prostanoids, providing physiological protection of the mucosa and reducing the frequency of adverse reactions from the GIT.
first_indexed 2024-04-09T16:35:53Z
format Article
id doaj.art-b88758227da647918d9f0fec78293805
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:35:53Z
publishDate 2017-11-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-b88758227da647918d9f0fec782938052023-04-23T06:56:54ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-11-0101712413110.21518/2079-701X-2017-17-124-1312134POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDEY. A. Olyunin0N. Y. Nikishina1Nasonova Scientific and Research Institute of RheumatologyNasonova Scientific and Research Institute of RheumatologyCurrently, nonsteroidal anti-inflammatory drugs (NSAIDs) are a major component of pharmacotherapy of chronic rheumatic pain and are the most commonly prescribed drugs. The cyclooxygenase (COX) – a key enzyme in the synthesis of prostaglandins (PG) mediating the inflammation development – is the target for NSAIDs. The use of NSAIDs is associated with risk of mucosal damage of the gastrointestinal tract (GIT). Its protection is carried out with the participation of PG, the synthesis of which is controlled primarily by COX1, to a lesser extent – by COX2, inducing an inflammatory process. Therefore, one of the most effective measures to prevent disorders of the gastrointestinal tract, was the development of drugs that selectively inhibit the activity of COX2. Such drugs include, in particular, nimesulide (NM Nimesin, Shreya Life Senses). In addition to synthesis of PG-mediated COX2, NM inhibits a number of other mechanisms involved in the development of the inflammatory process. The ability of the NM to act simultaneously on many parts of the inflammatory process allows successfully using it in various inflammation-associated disease. NM was covered in over 200 clinical trials that included more than 90 thousand patients with acute and chronic diseases accompanied by pain syndrome. These authors demonstrated that NM can significantly reduce pain, being not inferior by effectiveness than any of the NSAIDs both: selective and non-selective. At the same the sparing effect of NM on COX1 allows maintaining sufficient concentration of prostanoids, providing physiological protection of the mucosa and reducing the frequency of adverse reactions from the GIT.https://www.med-sovet.pro/jour/article/view/2157nimesulidecyclooxygenaseosteoarthritisrheumatoid arthritispain in the lower back
spellingShingle Y. A. Olyunin
N. Y. Nikishina
POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE
Медицинский совет
nimesulide
cyclooxygenase
osteoarthritis
rheumatoid arthritis
pain in the lower back
title POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE
title_full POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE
title_fullStr POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE
title_full_unstemmed POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE
title_short POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE
title_sort possibilities to use non steroid anti inlammatory drugs in clinical practice focus on nimesulide
topic nimesulide
cyclooxygenase
osteoarthritis
rheumatoid arthritis
pain in the lower back
url https://www.med-sovet.pro/jour/article/view/2157
work_keys_str_mv AT yaolyunin possibilitiestousenonsteroidantiinlammatorydrugsinclinicalpracticefocusonnimesulide
AT nynikishina possibilitiestousenonsteroidantiinlammatorydrugsinclinicalpracticefocusonnimesulide